| OPERATING ROOM |
Healthios clients can access exclusive project material and proprietary content in a secure and consistent environment.
CLIENTS… log-in»
Welcome to Cardiovascular Disease!
From late breaking news to key company press releases, from financings to who is investing, you will find it here.
Sector Performance ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Companies |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investors |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Calendar |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Executive Summary
02.26.10
by Stephen Cervieri, Managing Director - scervieri@healthios.com 1. Corporate Finance – Whither the VC Community2. News & Events – The Light of Healthcare Reform3. News Summary... more»Leadership Review
On January 15, 2009, Alan Timmins, a member of the Bioheart, Inc. Board of Directors, notified the company of his intention to resign from the Board of Directors effective immediately. ... more»
On January 15, 2009, Alan Timmins, a member of the Bioheart, Inc. Board of Directors, notified the company of his intention to resign from the Board of Directors effective immediately. ... more»
Mergers & Acquisitions
President of ROMlight International Inc., both shareholders of MedEmerg will join the board of AIM Health Group Inc. following completion of the transaction. ... more»
President of ROMlight International Inc., both shareholders of MedEmerg will join the board of AIM Health Group Inc. following completion of the transaction. ... more»
Corporate Finance
Bioheart Inc. announced that received a letter from Grant Thornton LLP notifying the Company of Grant Thornton's resignation as the Company's independent registered public accounting firm, e... more»
Bioheart Inc. announced that received a letter from Grant Thornton LLP notifying the Company of Grant Thornton's resignation as the Company's independent registered public accounting firm, e... more»
News & Events
ATS Medical Inc. reported the US launch and first clinical uses of the ATS CryoMaze(TM) Surgical Ablation Clamp.... more»
ATS Medical Inc. reported the US launch and first clinical uses of the ATS CryoMaze(TM) Surgical Ablation Clamp.... more»
Earnings Announcements
Stereotaxis Inc. reported unaudited earnings results for the six months ended June 30, 2008. For the period, the company reported that revenue totaled $17.7 million compared with revenue of $17.0 mill... more»
Stereotaxis Inc. reported unaudited earnings results for the six months ended June 30, 2008. For the period, the company reported that revenue totaled $17.7 million compared with revenue of $17.0 mill... more»
Legal & Legislative
CoreValve, Inc. announced that it has prevailed in a patent infringement lawsuit with Edwards Lifesciences in Germany.... more»
CoreValve, Inc. announced that it has prevailed in a patent infringement lawsuit with Edwards Lifesciences in Germany.... more»
Strategic Development
The new name and branding for MEDRAD, Inc.'s new interventional products division was unveiled to the public at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.... more»
The new name and branding for MEDRAD, Inc.'s new interventional products division was unveiled to the public at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.... more»
Clinical & Regulatory
Athersys, Inc.announced that it has completed patient enrollment for its phase I clinical trial of MultiStem(R), its allogeneic stem cell therapy product, administered to individuals following acute m... more»
Athersys, Inc.announced that it has completed patient enrollment for its phase I clinical trial of MultiStem(R), its allogeneic stem cell therapy product, administered to individuals following acute m... more»
